Stockreport

Arcutis to Present Two Posters at the 83rd American Academy of Dermatology Annual Meeting

Arcutis Biotherapeutics, Inc. - Common stock  (ARQT) 
PDF One poster will share pooled INTEGUMENT data of ZORYVE® (roflumilast) cream 0.15% in atopic dermatitis (AD) in patients with prior inadequate response, intolerance, and/ [Read more]